MedTrace Logo

Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis

NCT02721355 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2021-01-28

Study results available
· View outcomes & findings →

Summary

H. pylori positive patient volunteers that passed the selection criteria are recruited and divided into a test and a control group. Both groups are treated with a current treatment regime (EAC: Esomeprazole 40 mg/day; Clarithromycin 1000 mg/day; Amoxicillin 2000 mg/day) but only the test group received IgY-containing food supplement as an adjunctive measure for 15 days. The subjects are examined before and 4 weeks after the treatment initiation by Urea Breath Test (UBT) and gastro-endoscopy.

Conditions

  • Chronic Gastritis Caused by Helicobacter Pylori

Interventions

DIETARY_SUPPLEMENT

GastimunHP

Health food supplement containing specific IgY against urease of H. pylori

Sponsors & Collaborators

  • Dong Do Pharmaceutical Co.

    collaborator INDUSTRY

  • Immunology Research Institute in Gifu

    lead INDUSTRY

Principal Investigators

  • Khien V Vu, Ph. D · Dept. of Diagnostic Endoscopy, 108 Military Central Hospital, Hanoi, Vietnam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02721355 on ClinicalTrials.gov